Back to search

National and Kapodistrian University of Athens

Μελέτη της σχέσης βλαστικών κυττάρων και καρκίνου σε μοντέλα ποντικών

Abstract

dc:description

Besides embryonic, there are the adult or somatic stem cells. By definition, they have the ability to self-renew and differentiate into all cell types of a tissue. They are important for the natural tissue regeneration and can be mobilized upon injury. For certain cell types, it has been shown that they are the cells of origin of cancer. To isolate adult stem cells, there are markers based on functional methods. For validation of them, there are in vitro clonogenic assays and in vivo transplantations. One of the pathways involved both in stem cell maintenance and differentiation is the Notch signaling pathway. It is evolutionarily conserved in all metazoans, and plays a crucial role in embryonic development and tissue homeostasis. Therefore, deregulation or loss of Notch signaling leads to a wide spectrum of human diseases, including cancer, in various tissues. Its functions rely primarily upon the crosstalk of neighboring cells achieved through the physical interaction of transmembrane receptors (Notch 1-4) and cognate ligands. In mammals, there are 5 ligands: Dll1 (Delta-like 1), Dll3, Dll4, Jagged1 and Jagged2. This study focuses on the value of Dll1 as a putative stem/progenitor cell marker. The aim of the present study is to find additional markers of stem/progenitor cells in a variety of mouse tissues. In order to gain insight in the role of the Notch ligand Dll1 in mouse development, we generated a “knock-out/knock-in” line expressing a Cre recombinase. We use an inducible form of Cre recombinase (CreER), which becomes active only upon intraperitoneal injection with Tamoxifen. We have employed in vivo and in vitro approaches in mice to genetically mark rare subpopulations of cells expressing Dll1 in various adult tissues, with emphasis on the mammary gland, and stomach and skin that responded to KRAS oncogenic events. To assess recombinase activity, we crossed Dll1CreERT2 mouse with inducible fluorescent reporter lines, like the Rosa26mTmG mouse strain, which constitutively expresses a membrane-anchored tomato fluorescent protein and switches to membranous GFP expression upon Cre recombination. Using Dll1CreERT2;Rosa26mTmG bitransgenic mice, we observed Dll1-positive cells in the mammary gland, pancreas, intestine, stomach, kidney, bladder, liver, spleen and skin. In some of these tissues, the topology of Dll1 cells is compatible with literature, as to where stem cells are thought to reside. Activating mutations of KRAS are found in high percentage in various, epithelial mostly, tissues. Among the mutations of KRAS, the KRAS(G12D) is the most frequent one. To investigate the responsiveness of Dll1-positive cells to KRAS oncogenic signaling and their possible involvement as cells of origin of cancer in various tissues, we crossed KRAS(G12D) mice with Dll1CreERT2. An impressive finding was that when we conditionally expressed a constitutively active RAS oncoprotein in Dll1-positive cells, mice developed neoplasias in the skin, as well as in the stomach, only within days. Histological analysis of these neoplasms indicated squamous hyperplasias, but not invasion. So, the sparse Dll1 cells in the squamous forestomach and skin represent progenitor cells that are sensitive to KRAS oncogenic signaling. In the stomach, this is an equivalent model for human Barrett’s esophagus cancer. In addition, we expressed oncogenes or tumor suppressor genes, under the control of Dll1 and studied the effect of these genetic mutations on the Dll1 transformation process in the mammary gland. In Dll1CreERT2;KRAS(G12D) mice, we observed vigorous hyperplasia (simple, atypical or in situ) of luminal cells in mammary ducts, which is a precancerous stage in breast. This observation, in such a short period of time, contributes to the aforementioned conclusion that Dll1 cells are the progenitor cells of the luminal cells, from which breast cancer originates. Probably, due to the mortality of these mice, because of stomach and lips’ tumors, we were unable to observe tumors in the mammary gland. When we overexpressed KRAS in Dll1-positive cells, we obtained a more aggressive phenotype. Finally, PIK3CA is the most commonly mutated gene in human breast cancer, with the exception of TP53. When the most frequent mutation PIK3CA(H1047R) was expressed exclusively in Dll1 cells, we got similar hyperplasias of the ducts in the mammary gland. With Fat Pad assays, lineage tracing in vivo experiments in mammary gland and clonogenic assays in vitro, we concluded that Dll1 is expressed in both myoepithelial and luminal cells of mammary ducts. We believe that there are bipotent progenitors only during embryogenesis and they disappear during maturation of the mammary gland. Then, committed-lineage progenitors that are labeled by Dll1 are responsible for the regeneration of mammary gland. The increase of the number of Dll1+ luminal cells after multiple pregnancies implies that these cells contribute to mammary reconstraction following mouse weaning and mammary gland involution. Evadication of Dll1 cells has as a result the elimination of clonogenic capacity of mammary gland. Dll1-expressing cells are sensitive to KRAS signaling. Only Dll1-positive myoepithelial cells can reconstitute a fully functional mammary gland, under limiting dilutions. Finally, overexpression of hN1IC in Dll1 cells leads to a polycystic state of the liver, within 6 months to 1 year, a state before intrahepatic cholangiocarcinoma. In our future plans, we shall conduct experiments of lineage tracing and regeneration of liver, in order to prove that Dll1 cells are stem cells in the liver. In this PhD Thesis, we conclude that Dll1 cells are stem/progenitor cells in various mouse tissues, apart from intestine, where it is already known that these cells are the stem cells upon damage of the tissue, and that cancer originates from these special type cells.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Vasilaki, Eleni
  • Βασιλάκη, Ελένη

Subjects

dc:subject × 6

Rights

dc:rights
Statement dc:rights
  • BY_NC_ND
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/45273

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Vasilaki, Eleni; Βασιλάκη, Ελένη. Μελέτη της σχέσης βλαστικών κυττάρων και καρκίνου σε μοντέλα ποντικών. National and Kapodistrian University of Athens, 2019. http://hdl.handle.net/10442/hedi/45273